articleThe LancetAug 22, 2010Closed access

Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial

Jiangsu Provincial Center for Disease Control and Prevention · Xiamen University · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

798
total citations
FWCI
23.08
Percentile
100%
References
32
Citations per year

Authors

23

Topics & keywords

Keywords
  • Medicine
  • Placebo
  • Hepatitis A vaccine
  • Population
  • Internal medicine
  • Seroprevalence
  • Randomized controlled trial
  • Hepatitis A
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.